The burden of fatigue and quality of life in myeloproliferative disorders (MPDs)

2006397 citationsJournal Article

Authors

Ruben A. Mesa · WinnMed

Joyce Niblack · Sonoran Spine Research and Education Foundation

Martha Wadleigh · Dana-Farber Cancer Institute

Srđan Verstovšek · The University of Texas MD Anderson Cancer Center

John Camoriano · Mayo Clinic in Arizona

Sunni A. Barnes · Mayo Clinic

Angelina D. Tan

Abstract

The current study identifies fatigue as the major contributor to poor quality of life in MPD, provides baseline information on constitutional symptoms, and underscores the need for the incorporation of quality of life assessment in clinical trials.

Topics & Keywords

Myeloproliferative Neoplasms: Diagnosis and Treatment Chronic Myeloid Leukemia Treatments Kruppel-like factors research

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Cancer

Volume 109, Issue 1, pp. 68-76

DOI: 10.1002/cncr.22365

Field-Weighted Citation Impact: 2.97